Joint position statement on universal screening for GDM in Europe by FIGO, EBCOG and EAPM

Eur J Obstet Gynecol Reprod Biol. 2018 Sep:228:329-330. doi: 10.1016/j.ejogrb.2018.05.037. Epub 2018 Jun 2.

Abstract

Hyperglycaemia in Pregnancy (HIP) is a global issue as it increases risks for both the mother and child. There remains considerable disparity in clinical practice and national policies for HIP screening. FIGO, EBCOG and EAPM have joined forces to address this disparity in clinical care and reduce the burden of inter-generational Non-Communicable disease.

MeSH terms

  • Diabetes, Gestational / diagnosis*
  • Europe
  • Female
  • Humans
  • Mass Screening*
  • Pregnancy
  • Societies, Medical